UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  March 30, 2006

                            BIOLOK INTERNATIONAL INC.
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

         DELAWARE                  000-51482                  65-0317138
--------------------------------------------------------------------------------
(State or other jurisdiction      (Commission               (IRS Employer
     Of incorporation)            File Number)          Identification Number)

                              368 S. Military Trail
                            Deerfield Beach, FL 33442
--------------------------------------------------------------------------------
                    (Address of Principal Executive Offices)

                                 (954) 698-9998
--------------------------------------------------------------------------------
              (Registrant's telephone number, including area code)

                                      None
--------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant under any of the
following provisions:

|_|   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)
|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)
|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))
|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))

<PAGE>

Item 8.01 Other Events

      On March 29, 2006, BioLok International Inc. (the "Company") (OTCBB: BLLI)
issued a press release reporting an interview of the Company's President, Bruce
L. Hollander, by Wall Street Reporter in which Mr. Hollander discussed the
Company's growth strategies for its patented and FDA registered products. A copy
of the press release is attached as Exhibit 99.1.

The information under this caption, "Item 8.01 - Other Events," including
information in any related exhibits, is being furnished to the Securities and
Exchange Commission and shall not be deemed "filed" for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
otherwise subject to the liabilities of the Section. This information shall not
be deemed incorporated by reference in any filing under the Securities Act of
1933, as amended, or the Exchange Act, except as expressly set forth by specific
reference in such a filing.

Item 9.01         FINANCIAL STATEMENTS AND EXHIBITS

     (d)          Exhibits

Exhibit No.       Description
-----------       -------------------------------------------------------------

99.1              Press Release Dated March 29, 2006.

<PAGE>

                                   SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.

Dated: March 29, 2006                                 /s/ Bruce L. Hollander
                                                  -----------------------------
                                                  Bruce L. Hollander, President
{"company-data": {"conformed-name": "BIO LOK INTERNATIONAL INC", "cik": "0000840573", "assigned-sic": "3843", "irs-number": "630317138", "state-of-incorporation": "DE", "fiscal-year-end": "1031"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-51482", "film-number": "06728065"}, "business-address": {"street1": "312 S MILITARY TRAIL", "city": "DEERFIELD BEACH", "state": "FL", "zip": "33442", "phone": "9546989998"}, "mail-address": {"street1": "312 S MILITARY TRAIL", "city": "DEERFIELD BEACH", "state": "FL", "zip": "33442"}, "former-company": [{"former-conformed-name": "AMERICAN BIODENTAL CORP", "date-changed": "19950609"}, {"former-conformed-name": "MINIMATIC IMPLANT TECHNOLOGY INC", "date-changed": "19950609"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  March 30, 2006

                            BIOLOK INTERNATIONAL INC.
--------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

         DELAWARE                  000-51482                  65-0317138
--------------------------------------------------------------------------------
(State or other jurisdiction      (Commission               (IRS Employer
     Of incorporation)            File Number)          Identification Number)

                              368 S. Military Trail
                            Deerfield Beach, FL 33442
--------------------------------------------------------------------------------
                    (Address of Principal Executive Offices)

                                 (954) 698-9998
--------------------------------------------------------------------------------
              (Registrant's telephone number, including area code)

                                      None
--------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant under any of the
following provisions:

|_|   Written communications pursuant to Rule 425 under the Securities Act (17
      CFR 230.425)
|_|   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
      240.14a-12)
|_|   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))
|_|   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events

      On March 29, 2006, BioLok International Inc. (the "Company") (OTCBB: BLLI)
issued a press release reporting an interview of the Company's President, Bruce
L. Hollander, by Wall Street Reporter in which Mr. Hollander discussed the
Company's growth strategies for its patented and FDA registered products. A copy
of the press release is attached as Exhibit 99.1.

The information under this caption, "Item 8.01 - Other Events," including
information in any related exhibits, is being furnished to the Securities and
Exchange Commission and shall not be deemed "filed" for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
otherwise subject to the liabilities of the Section. This information shall not
be deemed incorporated by reference in any filing under the Securities Act of
1933, as amended, or the Exchange Act, except as expressly set forth by specific
reference in such a filing.

Item 9.01         FINANCIAL STATEMENTS AND EXHIBITS

     (d)          Exhibits

Exhibit No.       Description
-----------       -------------------------------------------------------------

99.1              Press Release Dated March 29, 2006.
SIGNATURES

      Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.

Dated: March 29, 2006                                 /s/ Bruce L. Hollander
                                                  -----------------------------
                                                  Bruce L. Hollander, President